GlassScriptPhysician profile
Christoph Michael Prummer
NPI 1740660638
$3,134.23
in general payments reported to CMS, 2019-2025
21 companies · $1,108 in 2025
The $1,108 reported for 2025 was more than what 81% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $59.07 · 2022: $486 · 2023: $818 · 2024: $662 · 2025: $1,108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,989 · Consulting Fee: $600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,988.91 |
| Consulting Fee | $600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $708.55 | 2022-2025 | Inspire |
| Verathon INC. | $600.00 | 2025 | Bronchoscope |
| Glaxosmithkline, LLC. | $432.82 | 2021-2025 | Nucala |
| Medtronic, INC. | $428.22 | 2023-2025 | Pteye Parathyroid Detection System, Stealthstation S8 Platform, Nim Vital |
| Genzyme Corporation | $184.39 | 2021-2025 | |
| Neurent Medical Limited | $147.42 | 2023-2024 | Neuromark Device, Neuromark Radiofrequency Console |
| Regeneron Healthcare Solutions, INC. | $113.14 | 2023-2025 | Dupixent |
| Kaleo, INC. | $88.37 | 2021-2022 | |
| Axogen | $64.86 | 2023 | Avance Nerve Graft |
| Preceptis Medical, INC. | $58.93 | 2023 | Hummingbird Tympanostomy Tube System |
| Alk-Abello, INC | $53.50 | 2024-2025 | Odactra, Grastek, Ragwitek |
| Astrazeneca Pharmaceuticals LP | $41.29 | 2023 | Fasenra, Breztri |
| Cochlear Americas | $37.76 | 2022 | |
| Aerin Medical INC. | $32.66 | 2025 | |
| Hologic Sales and Service, LLC | $30.43 | 2025 | Coolseal Generator |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $21.85 | 2025 | |
| Stryker Corporation | $21.13 | 2023 | Nasopore |
| Integra Lifesciences Corporation | $20.90 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Kowa Pharmaceuticals America, INC. | $16.31 | 2022 | |
| Merck Sharp & Dohme LLC | $16.13 | 2023 | |
| Genentech USA, INC. | $15.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christoph Prummer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.